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T H I 0 U R A C I L .._ ________ _ 
INTRODUCTORY AND HISTORICAL 
In 1941 MacK~nzie, MacKenzie and McCollum (1) during the 
course of some experimEnts to determine whether sulfaguanidine, 
when fed to rats on a purified diet containing synthetic B 
vitamins, might prevent the synthesis of additional essential 
nutrients by the intestinal flora, noted that the thyroid 
.glands became hyperemic and enlarged to several times the size 
of the controls. Histologically, the epithelium of the hyper-
trophied thJroids was columnar in type with papillary over-
growth, and there was an associated quantitative depletion of 
the intrafollicular colloid. The widespread and increasing use 
of sulfonamides at that time prompted them to further investig-
ation. 
Further studies by these same·workers (2) showed that an 
enlargement of the thyroid could be produced by other compounds 
of the sulfonamide series and by thiourea. This thyroid hyper~ 
trophy was accompanied by a marked drop in the basal metabolic 
rate. Both of ~heae changes were prevented or counteracted by 
the administration of thyroxin but not by iodine. 
At about the same time, Kennedy, Purves an~ Griesbach (3) 
(4) (5) reported the occurrence of thyroid hyperplasia in rats 
which had been fed the seeds of various species of' Brassicae, 
a genus of plants which includes cabbage, cauliflower, turnip 
and rape. The presence of associated histological changes in 
the pituitary glanis of' their animals suggested that the goi-tro-
genic effect was produced· through the mediation of the thyro-
- 2 -
tropic hormone of the anterior pituitary. In an attempt to 
isolate the goitrogenic substance present in rape-seed, KennedJ 
(6) was prompted to test the effect of a derivative of thiourea, 
allylthiourea. This substance, on oral administration, was 
round to produce changes in both the ._thyroid and pituitary of 
rats similar to those caused by a diet containing rape-seed. 
From a third laboratory, also at thi~ time, came the work 
of Richter and Clisby (7) describing the development of thyroid 
hyperplasia in rats, following the addition of phenyl thiourea 
to their drinking water. The MacKenzies (8) in an elaboratibn 
of their previous work, now stated that in addition to the 
anatomical changes in the thyroid and the drop in basal meta-
bolism previously noted with the administration of sulfonamides 
and· thiourea, thyroidectomJ cells were observed in the pituitary. 
Hypophysectomy prevented the characteristic changes in the thy-
roid. 
I 
A number of other investigators have been able to show that 
changes in the cellular pattern of the anterior pituitary are 
associated with dysfunction of the thyroid (9) (10) (11) {12). 
Marine et al (9) reported not only cellular changes in the 
anterior pituitary of' rabbits with parenchymatous goiter but 
also an increase in weight of the gland. Administration of 
iodine or dessicated thyroid was found to restore the cells to 
normal. MacKenzie et al (8) using diff'erential stains on the 
pituitaries of rats fed sulfonamides and thiourea was able to 
show a degranulation and decrease in the number of the acido-
• phils, vacuolation and increase in number and size of the baso-
phile. These changes corresponded closely to those reported 
following th7t-oidectomy (12), and were confirmed by Astwood 
-- 3 .. 
and his co-workers, (13). 
The above and similar studies on the mechanism whereby 
sulfonamides an~ithiourea induce thyroid enlargement led to. the 
concept that the goiter is compensatory in natureand that the 
primary action of such compounds is the inhibition of thyroid 
hormone synthesis (8) (13). This suggested to Astwood (14) 
that compounds related to the sulfonamides or thiourea might 
be useful therapeutic agents, and consequently the activity of 
a large number of such compounds was explored. The relative 
effectiveness of 106 chemical compounds in inhibiting the func-
tion of the thyroid gland was tested in young rats. These 
substances were administered in the food or drinking water for 
a period of ten days, the degree of gross and microscopic thy-
roid hyperplasia providing an est~ate of their activity. 
It was found that the compounds tested could be divided 
into three classes: thiourea derivatives, those containing an 
aminobenzene grouping, and the thiocyanates. The thioureas on 
the whole were the most active and among these, thiouracil had 
the highest activity. The aminobenzene derivatives included 
the common sulfonamides of which sulfadiazene was the most 
active. The thiocyanates were distinct from the other two 
classes in requiring a diet low in iodine,and their goitro-
genic action was completely inhibited by added iodide. With 
regard to this point, Rawson et al (15) have shown that the 
thiocyanate goiter readily takes up radioactive iodine while 
the enlarged glands resulting from thiouracil administration 
do not. 
Withreference to the compollllds tested, it was found t:b.at 
--
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all of the compounds having within their structure the group-
ing -NH•CS·NH- (thiourea and its deriv!:itives) were active, 
with the exception of those of very low solubility ip water 
or of high toxic1.ty. The inelusion ot; thiourea in a five or 
six membered heterocyclic structure resulted in a pronounced 
enhancement of activity (e.g. thiouracil}. The six membered 
heterocycles containing 3N atoms, however, although non-toxic 
in large doses, were of very low potency. 
Most of the heterocycles were of low toxi.city, and thio-
uracil and thiobarbituric acid, in addition to exhibiting an 
unusually high actlvity were particularly non toxic and there-
fore of greatest interest clinically. Thiouracil rankeu high-
est in both respects. 
From a structural point of view it was apparent that the 
entire grouping -NH•CS·NH- is essential to the thyroid, effect. 
Activity is lost if the S is replaced by another element or 
group as in urea, guanidine and their derivatives. Apparently 
both amino N atoms are essential, for activity is lost when 
one of these groups is absent. The S itself is obviously not 
the active agent as a number of compounds containing S in 
different forms were inactive. Therefore. it appear~ that 
the entire thiourea grouping is essential to the type of 
biological response under investigation. 
The biologically active grouping in the $econd series of 
compounds tested was not entirely clear, the only structure 
common to all being the aniline group NH~C~H~-· It is ap-
parently necessary that the amino group be free, for activity 
was lost when this group was substituted. 
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As a working hypothesis, Astwood (14J suggested that 
the aniline derivatives act through a competitive mechanism 
in the enzyme system responsible for the conversion of diiodo-
tyros1ne to thyroxin, the th1oureas being possibly specific 
inhibitors of the same system. 
.·~ 
........ 
...;-, 
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MECHANISM OF THIOURACIL ACTION 
Stimulated by the early reports, interest in the action 
began 
of thiourea and its derivativesAto increase and further 
evidence ~as accumulated supporting the view that these 
compounds inhibit the formation of thyroid hormone or depress 
the activity of the thyroid gland. The findings previously 
reported that the administration of thiourea to normal.rats 
resulted in an enlarged, hyperemic and hyperpiastic thyroid giand, 
coincident with a state of hyp·othyroidism as indicated by 
decreased food intake, decreased growth and development and 
by lowered basal oxygen consumption, were confirmed (13) (16). 
The thyroid hyperplasia was not influenced by large supplements 
of iodine but was abolished by the administration of thyroid 
powder and by hypophysectomy. The calorigenic action of thyroid 
powder was found to be uninhibited by these compounds in both 
normal and hypophysectomized rats. These facts were interpreted 
as evidence that the thyroid hyperplasia which occurs under the 
influence of these drugs was compensatory to the failure of 
thyroid hormone synthesis (13) (16). 
A number of further observations were made. The admin-
istration of thiouracil to young rats was followed by a nearly 
complete disappearance of iodine from the thyroid along with 
the hypertrophy of the gland. Withdrawal of the drug was 
followed by a prompt decrease in the size of the glands and a 
rapid reaccumulation of iodipe {16). Hughes (17) was able to 
show that the continued administration of thiouracil to rats 
from the time of birth resulted in a marked retardation of 
growth, arrested development, and changes similar to those 
seen in cretinism. . 
These effects were not observed if thyroxin was given con-
currently, offering further evidence that the observed results 
were brought about by an inhibition of thyroid activity. 
Similar results were obtained with tadpoles, where it was 
found that thiouracil in a concentration of 1:2000 inhibited 
the metamorphosis of Rama clamitans, ordinarily induced by 
injections of thyrotropin. Since the action of thyroxin in 
inducing metamorphosis was not inhibited, it was postulated 
that the drug p~events the production of thyroid hormone. 
I 
Experiments on the chick (19) (20) gave essentialiy the same 
results, the thfroid becoming markedly enlarged, their 
endocrine function inhibited, and a state analogous to 
cretinism being produced. 
The exact mechanism ot· thiouracil ac-e. ion has not as yet 
been definitely ascertained• The present hypothesis is based 
on the following eXperimental findings: 
1. Drugs of the thiourea series produce marked hyper-
plasia and enlargement of the thyroid, associated with evidences 
of diminished thyroid func~ion such as a decrease in basal 
metabolic rate (2) (8) (13) (16}-(20). 
2. When thiouracil is given to very young animals growth 
is checked and cretinism may be produced, indicating that 
thyroid hormone production is inhibited (22). 
3. Coincident with the thyroid hyperplasia and hyper-· 
trophy there is a definite decrease in thyroid iodine concen-
tration (16) {21). 
4. The thyroids of animals ·being treated with thiouracil 
remain low in iodine as compared to controls, regardless of 
the iod.1ne intake (15) (23) (c5) • 
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The greater portion of this iodine is inorganic. In untreated 
controls, however, the organically bound iodine comprises 
almost all of the demonstrable iodine. The concentration of 
inorganic iodine in the thyroids of controls is of the same 
order of magnitude as in animals treated with thiouracil. This 
indicates that this drug affects the synthesis of organic iodine 
compounds by the thyroid (16) (~5). 
5. The f'eeding of thiouracil to experimental animals has 
been shown to interfere with the incorp~ration of injected 
iodine into thyroxin amlc:cliiodotyrosine by the thyroid. (The 
thyroxin and diiodotyrosine,w~re determined as total organic thy-
·J ,~, . 
roid iodine.) This has also been demonstrated in vitro (26). 
6. On cessation of thiouracil administration, the iodine 
concentration in the thyroid increases to its normal level (16) 
( 24) ( 25). This increase -ilf:-due to an increase in thyroid 
organic iodine (26). 
7. The concurrent administration of thyroxin to thiouracil 
treated animals completely prevents the hyperplasia and other 
changes that normally follow thiouracil administration (13) (15} 
(161. It is not prevented by iodine or by diiodotyrosine.(l3) 
(15) (21) (2~). I-r. is, however, abolished by hypophysectomy, 
indicating that the pituitary mediates this effect (13). 
. 8. Thiouracil does not block the liberation of previously 
formed thyroxin from the thyroids. Any preformed and stored 
hormone ·continues to be secreted, altho~gh further synthesis of 
the hormone is inhibited (16) (~4) (27). 
9. ThiouraQil has no adtion on thyroxin itself. It 
interferes with the production of this hormone but not with 
its activity.(l3) (15) (1§}. 
- 9 -
As a result of this work the following •equence of events 
has been postulated (13) (14) (16). Shortly after thiouracil 
is administered the organism becomes unable to synthesize 
thyroid hormone at a normal rate. As stored hormone is used 
up the quantity of circulating hormone tends to fall as shown 
by protein-bound iodine determinations. In response to this 
( deficit an excess of thyrotropin is produced by the pituitary 
and this stimulates the thyroid to hyperplasia. So long as 
thyroid hormone is available in sufficient amounts the metabolic 
rate is maintained at a normal l.evel. Eventually, however, 
the stores of hormone are !~usted as evidenced by a complete 
loss of demonstrable colloid, and the metaoolic rate begins to 
fall even though the thyroid hyperplasia is still advancing. 
The actual level of hypometabolism reached depends partly upon 
the degree to which the process of thyroid hormone synthesis 
is hindered, partly on environmental and other factors which 
alter the thyroid hormone requirement. 
The discovery that thyroid hormone formation is prevented 
by sulfonamides and thiourea led Dempsey (28) to investigate 
the possibility that these drugs, which are well known anti-
enzymes, might act by poisoning an enzyme system necessary for 
the synthesis of the thyroid hormone. Since it had previously 
been established that the hyperplasia induced by the admin-
istration of thiourea and its derivatives was prevented or 
repaired by thyroxin (8) (13) but not by diiodotyrosine (22), 
it appeared that these antithyroid arugs might act by preven~-. 
ing the condensation of this compound into ,~;;:~\ail. Since 
peroxidase is present in many animal tissues, slnce it is 
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known to be poisoned by thiourea, and since it can catalyze 
reactions similar to the diiodotyrosine condensation, it appeared 
possible that this enzyme might also catalyze the form~tion of 
thyroxin. By means of the benzidine test on frozen thyroid 
sections Dempsey was able to demonstrate not only the presence 
of a true peroxidase in the follicular cells, but also the fact 
that its action was inhibited by thiouracil. 
The hypothesis thatthiouracil acts by preventing the con-
densation of diiodotyrosine into thyroxin does not exclude the 
participation of thiouracil in preventing the synthesis of 
thyroid hormone in other ways. ~e natural synthesis or thyroxin 
appears to involve two main steps: first, the iodization of 
tyrosine and second, the coupling of two molecules of diioao-
tyroaine to form thyroxin. The first uf these requires the 
presence of free iodine and, since exogenous ioct.ine is known 
to reach the· thyroid as iodide, a strong oxidizing sys~em is 
required to convert the iodide to iodine before diiodotyros1ne 
can be formed. • Peroxidase is known to be able to set free 
iodine from iodides. The failure of such a reaction in the 
thyroid gland could conceivably prevent the iodization of tyro-
sine and thus interfere with the thyroxin synthesis. While such 
a mechanism does not account for the failure of thyroxin synthesis 
on administration of diiodotyrosine to thiouracil treated 
animals, the postulation that thiouracil acts solely by prevent-
ing the etheric condensation of diiodotyrosine is in turn open 
·:. 
to the objection that the thyroids of animals treated with this 
d~g show an almost complete disappea:rance of organic iodine 
which is presumably at least in large part diiodotyrosine and 
thyroxin. Thus, all that can be said at present is that 
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thiouracil blocks thyroid hormon~ synthesis, the mode of 
action being either prevention of tyrosine iodization or of 
diiodotyrosine condensation or of both. 
THYROID HORMONE ASSAY WITH THIOURACIL 
The findings_ that thyroid hormone synthesis is inhibited 
in animals by thiouracil but that this drug has no effect 
on thyroxin itself has suggested a method of thyroid hormone 
assay to several workers. (20) (22) Both chicks (20) and 
rats (22) have been used. The assay in general consists of 
determining quantitatively the effect of various thyroid pre-
paration in maintaining or restoring normal thyroid weight in 
thiouracilized animals. 
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PHYSICAL AND CHEMICAL PROPERTIES 01<' THIOURACIL 
Little or no data on the properties of thiouracil seem 
to have been published since Wheeler and Liddle (29) reported 
the synthesis of this compound in 1908. Thiouracil is a 
heterocyclic derivative of thiourea, and has the following 
formula HN---cc=o 
I I 
C::S C-H 
I If 
HN C-H 
It is a white, oderleas, bitter powder, insoluble in alcohol, 
CCl4, acetone and mineral aoi?s, and somewhat soluble in ether. 
A saturated aqueous solution contains about 50mg. of thiouracil 
per lOOcc. at 250 c. Due to its acid properties it forlll8 very 
soluble salts on addition of Na or KOH to an aqueous solution. 
It is relatively stable in solution, more so in dry form, ana 
is not affected by sunlight. (30) 
Several methods all employing Grotes' reagent have been 
published for the determination of thiourea and thiouracil in 
serum, urine, tissue extracts and body fluids. (30) (31) This 
s 
reaction depends on the fact that the >N-~-N< linkage of thio-
uracil reacts with sodium nitroferricyanide in alkaline solu-
tion (Grotes' reagent) giving a greenish color which can be 
quantitated in a colorimeter. 
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ABSORPTION, TISSUE DISTRIBUTION AND EXCRETION OF THIOURACIL 
Experimental studies on both an~ and man have shown 
that thiouracil is rapidly absorbed from the gastro-intestinal 
tract (80~ in two hours). Following the administration of 
0.2 gm. of thiouracil to a normal individual, Williams and 
Bissell (35) found a high blood level (2.3 mg. lOOcc) was at-
tained after 15 minutes. This fell rapidly until at eight 
hours only 0.3 mg lOOcc. was present; the drug, however, did 
not entirely disappear until the third day. The most rapid 
rate of e.xcr·etion of the drug occurred during the second hour. 
When thiouracil was given in doses of 0.2 gm. at four 
hour intervals, it required about 24 hours to reach a more or 
less constant blood level (about 3mg. lOOcc) and rate of 
urinary excretion (300-s. daily). When the dosage was 0.2gm. 
three or four tiues daily, about 48 .hours were required. (35) 
Frequent small doses were found to maintain a greater 
constancy in the blood and urine levels than did equivalent 
daily amounts administered less frequently. (34) In a series 
of patients given dosages varying from 0.2 to 1.2@M• daily, 
the blood levels were found to remain relatively constant, 
regardless of what dose in this range was given. (33). 
On ingestion of thiouracil, all of the drug was found to 
be either absorbed or broken down in the gastro-intestinal 
tract. In patients receiving from 0.4 to l.Ogm. daily, ap-
proximately one-third is excreted unchanged in the urine. On 
the average, 15~ of the quantity ingested is destroyed 1ft the 
gastro-intestinal tract, 33~ excreted in the urine and the 
remainder is broken down in the body tissues and fluids.(32)(34) 
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In an effort to determine the end products of thiouracil 
metabolism sulfur balance studies were undertaken. (32) (34) 
These revealed an increased excretion of urinary neutral 
sulfur. The other end products of thiouracil metabolism have 
not yet been determined. 
After absorption, the drug is distributed throughout all 
of the body tissues and fluids, the thyroid, pituitary, adrenals 
and bone marrow storing the largest amounts. Skin, muscles and 
liver contained the least. Thiouracil in the blood is largely 
bo~nd to protein, the cells possessing several times as much 
as the plasma. Cerebrospinal fluid, edema and pericardial 
fluids were found to contain distinctly less than did whole blood, 
the concentration in pleural and ascitic and aseiti~.fluid 
was about equal to that ''Of blood, and milk was found to con-
tain about three times as much. (33) 
There is also evidence that thiouracil can pass through 
the placenta. (17) (64) 
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EXPERIMENTAL DATA ON THICURACIL TOXICITY 
Published studies on the toxicity of thiouracil for 
experimental animals are meager but indicate that the drug 
has a relatively large margin. of safety. Astwood (14) found 
that toxic manifestations do not occur in rats until a daily 
dose of 100 mg. per 100 gm. of body weight is ex?eeded. 
When thiouracil was fed at a~ve~ of 1% of the diet, con-
cretions in the urinary tract were observed in about one 
third of the animals. Animals surviving this complication 
have been maintained on this dosage for five months without 
showing signs other than those attributable to:.,.a state of 
hypothyroidism. This dosage amounts to more than 100 times 
the minimal effective dose for thyroid hyperplasia and about 
20 times the amount required for a. fUll thyroid e~ect. 
Williams and his co-workers (36) have reported the results 
of an investigation of structural alterations produced in rats 
fed thiouracil in relatively large doses (0.25% solution as Na 
salt, in the drinking water) for intervals of from five to nine-
ty days. In more than 700 microscopic sections made from essen-
tially all of the tissues of the body of many series of rats, no 
notable alterations were found which were attributable to thio-
uracil with the exception of those in the thyroid gland. The 
blood levels of these animals were distinctly higher than those 
encountered in man. Six patients who were given thiouracil for 
from 6 to 28 days preceeding death, were not found on post-mortem 
examination to show any gross or microscopic effects of this drug. 
With a dosage of one gram or less daily, the drug has not been 
found-to accumulate appreciably in the blood, in spite of the pre-
sence of severe disease of the kidneys or liver (37). 
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Studies made on the effect of thiouracil therapy on various 
metabolic processes have demonstrated that blood Na, K and Cl 
levels are unaffected by this drug. No appreciable change was 
fQund in the glucose tolerance, ~d no evidence of liver damage 
could be found. The figures for blood proteins and blood phos-
phatase were found to remain within normal limits (38). 
The toxic effects reported in the clinical use of this drug 
• will be considered separately in another section. 
HYPERTHYROIDISM - ETIOLOGY, CLINICAL PICTURE, AND 
PATHOI.DGY ( 39') ( 40) { 41) 
Hyperthyroidism is a disease in which the thyroid gland 
produces and releases its hormone in amounts exceeding the 
nhysiological needs of the organism. There are tr1o main types: 
exophthalmic goiter (Graves• disease, thyrotoxicosis, Basedow•s 
disease) and toxic adenoma. 
A. Exophthalmic goiter 
This is apparently a disease of civilization, occurring 
most frequently among young adults in cities where life is stren-
uous, and esp~cially in people of narrow frame, light skeletal 
structure and nervous temperament. Women are much more often 
afflicted than men. It bears no apparent relationship to iodine 
deficiency. In a large percentage of cases, nervous shock or 
strains play an important role and cures are difficult until 
this strain has been relieved. 
The thyroid gland in this condition shows a diffuse en-
largement. and becomes soft and very vascular. Microscopically, 
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the acini show hypertrophy, hyperplasia. and infolding of cells. 
The amount of colloid is diminished and there is lymphoid hyper-
plasia. The gland iodine content is low, but the blood organic 
iodine is elevated. After iodine administration the gland tends 
to assume the histological appearance of colloid goi.ter and a 
temporary remissmn of symptoms may occur. 
The patient with exophthalmic ~oiter ma~ show a number of 
characteristic features. 
1. the blood supply of the gland is greatly increased, 
the rush of blood through the superior thyroid arteries often 
producing a ~oud bruit or a distinct thrill. 
2. the thyroid is enlarged. 
3. the patient may complain of easy fatig~abilitJ, 
nervousness, irritability. 
4. loss of weight despite an increased appetite. 
5. tachycardia is present. This may progress to 
auricular fibrillatton. The patient may also complain of 
palpitatior.t. 
6. fine tremor of the hands. 
7. the skin is warm and moist. There is usually a 
sensitivity to heat. 
8. vomiting and diarrhea may develop. 
9. the basal metabolic rate may reach as high as +125 
ot':even higher. 
10. exophthalmos - the eyes develop a staring expression 
with the whites very prominent. 
11. winking is infrequent and other eye signs such as 
lid lag may occur. 
Most of these SJMptoms are d~rectly referable to the in~ 
creased thyroid secretion. 
The cours~f the disease varies. It may be acute and 
I 
fulminating, the patient dying with all the classical symptoms 
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of exophthalmic goiter. Sometimes there is an acute exacerba-
tion of symptoms after thyroidectomy or during the course of 
the disease, the patient dying in a so-called thyroid storm 
usually from exhaustion or cardiac failure. In other cases the 
course is less violent and is marked by a series of remissions 
and exacerbations. In all patients who have suffered from 
exophthalmic goiter there is danger of recurrence even after 
operation. 
B. Toxic Adenoma 
A thyroid gland which has gone through any degree of hyper-
plasia and involution has a.marked tendency to develop nodular 
formations which are co~rnonly known as -adenomas. Most adenomas 
produce no symptoms except mild disfigurement and pressure. A 
small number become toxic, a very small percentage malignant. 
A simple adenomatous goiter may undergo an increased func-
tional activity and produce the features associated with hyper-
thyroidism. This toxic change most usually occurs between the 
ages of 35 and 40. The onset of the constitutional symptoms is 
often without aPParent cause butit may be initiated by the ad-
ministration of iodine and, once started, continues even after 
the iodine has been withdrawn. The patient usually gives a 
history of having hade, a swelling of the neck for many years. 
There is a gradual onset of symptoms with a rising BMR which 
reaches an average of about +30 but may be higher. Exophthalmos 
seldom occurs, A S'lt@':!6l!l'deli eJ~li!!Ut~iU:eft ie wft:e face tlhat bsxlc 
e:Eleftellll!l af'f'ee:Ps la$ep !B life tile:B ewe,aeft:almie ~eieet, iae: at 
"l!ieh ls eapa'bl:e 
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al •s••*'•e vlele:R1ilf 1i1 ilhe Bilitl:llltt:e; :ee 1ihs1i 8Jl8J!lAri:kalai• 
lB ae:eea1i and the nervous symptoms are less marked. On the 
other hand, the myocardium is more e~sily exhausted and fibril-
lation more readily produced. 
At one time it was thou~t that exophthalmic g6iter and 
toxic adenoma showed dlstinct differences in etiology, symptom-
ology, course, and response to treatment. Most observers now 
feel that there is no essential difference between the two but 
that they are clinical variations of a single disease. 
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TREATMENT OF HYPERTHROIDISM-WITH TEIOURACIL 
In view of the finding in animals that the formation: of 
thyroid hormone is inhibited by relatively non-toxic compounds 
it seemed of interest and importance to determine whether the 
excessive production of hormone""in human thyrotoxicosis could 
be checked by the administration of one of these agents. 
The first compound to be tested clinically was thiourea, 
which appeared to be particularly non-toxic in animals. During 
the early part of 1942 several normal and hyperthyroid indiv-
iduals were given from one to two gram·doses of this drug for 
several days. No toxic effects were noted and there was no 
immediate change in the metabolic rate. When treatment was 
continued for several weeks improvement of thyrotoxic symptoms 
and a satisfactory response of the BMR were observed (42). 
This effect of thiourea was confirmed and extended by 
Himsworth (43), who treated six patients with hyperthyroidism 
with good results. Thiourea was found to be unpleasant to some 
persons because of the aftertaste and because of the unpleasant 
odor imparted to the breath. Some of the patients experienced 
nausea and vomi~ing and the develop.ment of a skin rash when 
treated with adequate doses of this drug. Other unfavorable 
side effects with this drug have been reported (44) (45). In 
general it appeared that the activity of thiourea was too low 
and the incidence of a· toxic reaction too high for it to be 
recommended as a useful drug. 
Shortly after the first successful trials with thiourea 
had been initiated, a study ·or the activity of a number of re-
lated compounds revealed that thiouracil was a more highly 
active drug (14). As a result most of the studies on the 
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chemotherapy of thyrotoxicosis have been confined to this drug. 
When thiouracil was tested in clinical hypertn,yroidism its 
high activity was soon apparent. A total daily dose of from 
0.2 to 0.6 gm. was tound to be effective in controLLing the 
symptomspf hyperthyroidism an~ in reducing the BMR to normal (42). 
I 
In one case a dose of 2 gm. da~ly resulted in a severe but temp-
orary agranulocytosis serving to show that caution and close 
observation are essential wnen this drug is being given. 
The first published confirmation of the clinical effect-
ivenes~of thiouracil was that of WilLiams and Bissell (35) who 
treated nine patients with doses of about one gram daily. 
Hyperthyroidism was adequately controlled and no raer,:tous toXic 
manifestations were noted. It has recentLy been indicated by 
Gabrilove and Kert (46) that doses of this order of magnitude 
are not safe since three out of their nine patients so treated 
showeu toxic manifestations. 2 consisting of fever and one of 
leucopenia. 
To date a sufficient series of cases have been treated 
with thiouracil to form the basis for at least a preLiminary 
estimation of its value in hyperthyroidism. The following 
reports have been consuLted in arriving at the conclusions 
presented beLow. 
(Taole on next page) 
""' 
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Reference No.of Cases No.treated Continued No.treated 
Reported Medically Remissions with Thio-
on Cessation uracil Pre-
of Thio- operatively 
uracil 
Rawson et al (27} 19 0 19 
Astwood (42) 1 1 
Williams et.al (05) 9 9 
Palmer (47) 12 12 
Gabrilove et a1 (46) 9 9 
Paschkis et a1 (45) 15 12 1 3 
Grollman et a1 (48) 18 0 16 
Rose et al (49) 37 37 8 4 
Watson et al (50) 11 11 
McGregor (51) 20 20 
Reveno (52) 9 9 
McGavack et al (38) 26 26 
Moore et a1 (53) 50 19 ~4 
Clute et al (37)(54) 115 81 34 
Astwood (55) 62 62 9 
Bartels (56) 11 0 11 
427 308 18 ' 121 
The low number of comple·te remissions on cessation of 
therapy is due primarily to the fact that few investigators 
have as yet published reports on the results of discontinuance 
of the drug after adequate therapy. The Lahey Clinic has used 
thiouracil preoperatively on some hundreds of patients with 
excellent results although statistical data has'enot as yet 
been published. (57) 
Dosage 
The first clinical dosages were determined on the basis 
of the minimum amount of the drug required to produce a com-
plete or nearly complete inhibition of thyroid hormone syn-
thesis in the rat, the results being transposed to man on 
the basis of body weight. (55) As more and more data became 
available it became obvious that the amount of drug necessary 
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to obtain an adequate response in thyrotoxicity was distinctly 
less than the~ount~irst used (1 to 1.2gm. or more per day) 
and the dosages were accordingly lowered. A scheme of medica-
tion found satisfactory by Williams and Clute (37) in a series 
of 72 cases treated medically with this drug consisted of 
0.2gm. t.i.d. for the first 2 weeks, followed by 
0.2gm. b.i.d. until the BMR is normal 
O.lgm. b.i.d. is then instituted and this dosage 
continued until the BMR has been maintained well within normal 
limits for several weeks. At this point, the dosage can be 
reduced to o.lgm. daily as a maintenance dose. Only rarely 
we're larger doses f'ound necessary. 
Astwood,who has done considerable of the early work with 
this drug, in his report on treatment of' 62 patients (5b) used 
total daily dosages of' 0.3 to 0.6gms. initially, reducing this 
to 0.2 to 0.4gm. within five weeks. In his more recent work 
this has been reduced even further with satisfactory results. 
The dosage now employed is 0.4grn. daily in two doses of 0.2gm. 
each at twelve-hour intervals. Larger doses and a further sub-
division of the daily dose do not appear to be more effective. 
(33) (58) As little as 0.2gm. daily in two doses has been 
eff'ective and in only a few eases did 0.3gm. daily appear in-
adequate. Currently, a dose of 0.6gm. daily is given only to 
large individuals and to those in whom a slow response is 
anticipated. Since instituting this reduction in dosage, 
Astwood has noted no toxic reactions of any consequence. 
Whatever schedule of dosage is used, it should be borne 
in mind that thiouracil is rapidly absorbed and excreted. Thus 
it is better to give 2 or 3 decreased doses per day than one 
large dose. 
0 
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Response to Thiouracil Therapz 
The patient may remain ambulatory during thiouracil treat-
ment although a short period of hospitalization at the onset 
of this therapy for purposes of study has been advocated. The 
patient may then be released and followed by hospital visits at 
intervals. The more seveniy thyrotoxic patients are best kept 
in bed. Sedatives are given at the beginning of treatment if 
necessary, phenobarbital giving good results. As improvement 
progresses under continued therapy, sedatives can usually be 
dispensed with. A high caloric diet, rich in carbohydrates 
and protein, supplemented by Vitamin B complex is prescribed 
routinely. (54) (57) 
The usual pattern of response in previously untreated 
cases of Graves• disease~ as follows. When an adequate control 
period of rest in bed and sedation is&lowed before thiouracil 
is begun, an estimation of the rate of response_ to this therapy 
can be obtained by frequeza:t;:G.etePmina t ions of the basal metabolic 
rate. Usually, about a week of treatment was required before a 
distinct effect was obtained. Once the metabolic rate had begun 
to fall it continued to decline in a fairly regular manner for 
the next seven to ten days, then exhibiting considerable indivi-
dual variaU on. In some eases the response continued rapidly 
and the metabolic rate reached normal levels within tW) weeks 
although on the average, three weeks were required. 
Clinical improvement seemed to parallel quite closely the 
fall in metabolic rate. Subjective improvement was usually 
claiaed almost iMmediately after therapy was instituted and 
before there were any objective signs of a therapeutic effect 
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but an evaluation of this phenomenon is not a~ present possible. 
Other indices of improvement which paralleled closely the meta-
bolic response were weight gain, slowing of the basal pulse rate, 
return of protein-bound blood iodine to normal, and a decrease in 
tremor. After the metabolic rate had reached normal, most of 
the signs and symptoms of hyperthyroidism had disappeared. In 
most instances muscular weakness was the last symptom to clear 
and usually it continued until after the normal body weight had 
been regained. 
The daily dosage of drug is gradually reduced and a main-
tenance dose is established (i.e. the lowest dose compatible 
with continued regression of signs and symptoms). Adequate treat-
ment continued for longer than six months was attended by a high 
A incidense of lasting remissions on cessation of therapy •. (49) (55) 
Exophthalmos was not obviously influenced during the first 
few weeks of treatment. There is some doli> t in the literature 
as to whether regression of the eye changes does occur under 
this therapy. (37) (49) (55) Williams and Clute (37) have re-
ported five cases in whicll the ocular manifestations became 
worse during the first few weeks of thiouracil treatment. Pre-
sumably, when the production o~hyroid hormone is markedly in-
hibited, there results an excessive production of thyrotropic 
hormone which in turn caus~s hyperplasia of the acinar cells 
of the thyroid and certain manifestations of mqlignant exoph-
thalmos. Thus with the use of thiouracil, especially in exces-
sive quantities, in thyrotoxic patianta., a still greater enla.rge-
ment of the thyroid may resu~t and the manifestations of malignant 
exophthalmos be accentuated. Under such conditions, it is ad-
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visable to reduce the dosage of thiouracil. In some cases the 
use of dessicated t-hyroid also seems. indicated since it not o.nly 
inhitt-ts the production of thyrotropic hormone but also exerts 
a diuretic effect that is of advantage in the control of severe 
cases of malignant exophthalmos. On an empirical basis, best 
re~ults were obtained by decreasing thiouracil to a sufficiently 
small dosage to maintain a normal BMR and then giving 1 to 1.5 
grains of dessicated thyroid daily. In general, in individuals 
showing manifestations of malignant exophthalmos, the minimal 
effective dose of thiouracil should be used to bring the meta-
bolism to normal since overtreatment may lead to an increase in 
the exophthalmos. 
The size of the thyroid gland does not exhibit constant 
changes during therapy. The gland was noted to become softer, 
however. In patients with large diffuse goiter, there was 
usually an increase in size during the first few weeks and an 
increase in the signs of hyperemia, followed by 9. slow regression. 
Patients previously treated with iodine were found to ex-
hibit a greatly delayed response to thiouracil. Presumably 
iodine therapy tends to cause the deposition of large stores 
of thyroid hormone within the gland. These must be exhausted 
before an effect upon the metabolic rate can be achieved. The 
action of the drug is to block the formation of new hormone and 
it is without effect on th~elease or the activity of hormone 
already sto~ed within the gland. It has cons~quently been the 
reeent practice to discontinue iodine, if being given, for some 
weeks prior to starting thiouracil therapy,if possible. 
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Long latent periods have also been noted in several in-
stances of toxic nodular goiter and in these as in the iodine-
treated cases of Graves' disease, there is presumably a large 
amount of hormone-containing colloid within.the gland, and pre-
sumably the same mechanism is operative in causing a delayed 
response. This factor is apparently also responsible for the 
fact that in person~ith normal glands a prolonged period of 
treatment is required before a fall in the metabolic rate oc-
curs. In the normal individual, there is a large store of hor-
mone and the time required for the gland to become depleted 
is further extended by the fact that the rate of release of 
hormone is much slower than ia the case of the overactive glands 
of hyperthyroid individuals. 
The effects of adequate thiouracil therapy in hyperthyroid-
ism may be summarized as follows: 
1. The BMR and protein-bound iodine are reduced to normal 
limits. 
2. Symptoms of hyperthyroidism are in general relieved. 
3. Thyroid hyperplasia and vascularity is increased, 
and there is loss of colloid from the gland. 
4. The avid1ty of tbe ~~pyroid for iodine is decreased. 
5. Complications, either toxic or allergic may some-
times occur. These may require either permanent or temporary. 
cessation of treatment. (This is more fully discussed in a 
separate section below). 
6. Exophthalmos tends either to remain stationary or 
to increase, although some apparent remissions have been re-
. ported. 
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In addition it should be, pointed out that overdosage 
may result in a myxedematous state but that this is easily 
controllable by temporary cessation of therapy or readjust-
ment of the dosage. 
A few studies have been reported on the effect of thio-
h 
uracil on the disturbances in Ca., P, N, creat.ive - creatinine, 
cholesterol and 17 - ketosteroid metabolism in hyperthyroidism. 
(60) {38) The results, demonstrating that all these various 
metabolic defrangements were corr~cted by the administration 
of thiouracil just as occurs after subtotal thyroidectomy,may 
be considered as further evidence that the remissions produced 
during use of this drug are physiologic. 
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Remission and Th1ourac11 Therapz 
After the full effect of thiouracil therapy is achieved 
as gauged by clinical improvement and return of pulse rate and 
BMR to normal, two courses are open for permanent maintenance 
of those patients scheduled for medical treatment. Inasmuch as 
experimental and clinical observations have shown that tr1e 
effect of the drug is reversible, treatment may be either a) 
discontinued until signs and symptoms of hyperthyroidism re-
cur' and then reinstituted (intermittent treatment) or b) main-
tained and an attempt made to establish a small permanent main-
tenance dose. In the first few_ treated patients therapy was 
withdrawn shortly after the metabolic rate had reached normal 
in order further to establish that the observed effect was at-
tTibutable to~the drug. ~e results sl1owed that all the mani-
festations of the disease returned promptly when treatment was 
discontinued and that no lasting improvement could be obtained 
from short periods of medication. In subsequent cases (55) the 
treatment was continued for an arbltrary period of from six 
to eight months in dosages that maintained a normal or some-
what subnormal metabolic rate. During this period the patients 
remained free of symptoms and appeared normal in every way with 
the exceptions usually of continued eye signs where originally 
present, and thyroid enlargement in some cases. At some time 
during this period of treatment a spontaneous remission pre-
sumably occurs. Of twelve patients who have thus f'ar completed 
such a course of therapy (55) and from whom the drug has been 
withdrawn, nine have remained symptom free for periods ranging 
from two to six moriths. As the effect of the drug subsides in 
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a few days after the last dose (35), it must be presumed that 
remissions occu~. Since there is no experimental basis at pre-
sent for assuming that thiouracil was responsible for the re-
missions it is more reasonable to suppose that the drug merely 
controlled the disease and maintained a state of health which 
permitted a spontaneous and apparently complete recovery to occur. 
PSYCHOGENIC ASPECTS OF HYPERTHYROIDISM 
The importance of psychic factors in the etiology of n,per-
thyroidism has already been mentioned. There is, moreover, 
evidence to indicate that thyrotoxicosis is essentially a bi-
phasic disorder - one phase the result of cellular metabolic 
changes produced by thyroid .hormone in excessive amounts; and 
the other a more fundamental etiologic process related perhaps 
either to the pituitary or autonomic nervous system or both. 
It is well established 1 for example, that thyrotoxicosis 
may recur in the same individual even after several partial 
thyroidectomies each of which may give some degree of temporary 
relief. It is also known that symptoms of this condition may 
be retained even after subtotal thyroidectomy or thiouracil has 
reduced the BMR to within normal limits. Moss (59) has cited 
similar cases in which amelioration of symptoms did not occur 
with reduction of the BMR until psychotherapy had been instituted. 
From examples such as these it would seem that eontrol of the 
cellular metabolic abnormal! ty alone does not always suffic·e to 
produce a: cure so long as the fundamental underlying etiological 
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factors remain unchanged and the body is unable to cope with 
them. 
An attempt to present an outline of the role of psychic 
factors in hyperthyroidi~m has been made by Moschowitz. (60) 
He conceives of a constitutional type in whom there develops 
an exaggeration of normal body function (elevated BMR) with sub-
· sequent morbid anatomic changes which become fixed as hyper-
thyroidism. His picture of the hyperthyroid diathesis is that 
of a shy introverted person, very sensitive and responsive to 
his environment, tending to be of the manic-depressive type. 
The person is phys~.cally and mentally quick but also tires 
quickly. Most of the patients studied had a childhood history 
of unsuccessful family adjustment, and an inability to adjust 
to an adult environment due to overprotection in early life. 
There was frequent escape from realities. All the patients 
showed sexual difficulties of one sort or another. The onset 
of the disease in this constitutional type is ushered in by a 
severe psychic insult for which the patient is unprepared. Fear 
is an essential ingredient to this insult. Exophthalmic goiter, 
from th~s viewpoint, may then be considered as an incident in 
the life history of a personality disorder associated with 
emotion and due to an acute panic state. (59) Thus, the physician 
must consider the ability of the patient to meet the stresses 
of his daily life in the environment to which he returns after 
the \tpyroid.aspects of the disease are controlled. Psycho-
therapy may be of importance in these cases if a lasting cure 
is to result. 
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It has already been noted that in those cases in which 
remissions have continued after cessation of thiouracil therapy, 
the patients had been maintained at a normal metabolic rate for 
long periods ot· time (6-8 mos.) before the drug was withdrawn. 
In the absence of any evidence of a return of the disease when 
the drug is discontinued it must be ccncluded that some change 
in the endocrine system has taken place which has permitted the 
patient to return to a normal physiological state. It is not 
known with certainty what pathologic changes cause hyperthy-
roidism and it is impossible to say whether thiouracil treqt-
ment modifies the cause of the disease. It is possible, however, 
J 
that the disturbin£ effecmof hyp.thyroidism contribute to the 
maintenance of the disease, and that only if thiouracil is con-
tinued long enough will it provide a sufficient interval during 
which recovery can take place. If the etiological factor is 
indeed psychic trauma as~suggested above, a combination of thio-
uracil for immediate control and psychotherapy for etiological 
control may prove to be the ideal method of treatment in terms 
of permanent results. 
A number of important questions still re~ain to be answerea 
regarding the effect and clinical usefulness of thiouracil, 
' 
especially with respe~,t to 1ts prolonged use for the medical 
treatment of hyperthyroidism. F'or example 
1. The possibility of late toxic effects following 
prolonged use of this drug cannot at present be eliminated. 
It is pos~ible for example that depression or exhaustion of 
the bone marrow may follow prolonged ingestion ot this drug in 
some casee. 
• 
• 
2. What undesirable dislocations of endocrine relation-
ship may be. induced by prolonged inhibition of thyroid. hormone 
production and the consequent disturbance of the thyroid~pituitary 
balance? Is there a possibility that hyperfunction of the 
pituitary might eventually be produced, or that pituitary ex-
haustion might ensue? With regard to this point it may be 
recalled (32} (34) that the drug, after absorption, is found 
in largest amounts in the thyroid, p1tuitary, adrenals and bone 
marrow. 
3. Is it possible that the maintenance of a chronically 
hyperplastic state of the thyroid might be followed bl fibrosis, 
or atrophy, or neoplastic change? 
4. How long must eases remain under treatment before a 
permanent cure is effected? 
5. Could the therapeut'fc response in thyrotoxicosis be 
enhanced. by the coincidental use of anti pituitary agents such 
as estrogens, etc? 
The observation of many more cases over a much longer 
period of time is necessary before these questions can be 
answered and before the usefulness of thiouracil in the medical 
treatment of hyp~rthyroidism can be ultimately evaluated. 
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TOXIC REACTIONS RESULTING ¥ROM THE CLINICAL USE ~1 THIOURACIL 
Since the extended use or thiouracil will depend chiefly 
on whether its benericial errects can be obtainea without in-
curring undue risk as a result of its toxic action, a careful 
evaluation or this point is primary to any considerat~on or the 
problem as a whole-. McGavack and his co-workers (68) have col-
lected one hundred thirty-five cases treated with thiouracil bJ 
various investigators. (all eases reported up to that time) and 
reviewed them in relation to toxic symptoms. 'I'he results of 
their findings are given below: 
Sixteen of the one hundred thirty-five patients developed 
toxic reactions. The majority of these have involved the hemato-
poietic system. 
1. Agranulocytic angina was reported in two patients. 
2. Leukop~nia and relat+ve lymphocytosis - six patients. 
It was felt that tills complication does not warrant 
complete cessatjon or therapy but that such responses may per-
haps be considered an indication ror temporary or permanent 
decrease in the size of the dose used, since in three cases the 
reaction subsided without interrupting the treatment. 
3. Fever - This was the chier toxic manifestation in four 
of' the cases. The common associa. tion of urticarial skin rashes, 
the rl~ctuant nature of t~e fever, and the smallness of the 
total dose received (less than 5gm.) led to the conclusion that 
such reactions are probably more in the nature of' a true sen-
sitivity than the end result of a cumulative toxic reaction~ 
4. Diarrhea - reported as the only toxic manifestation 
in one patient. 
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5. Slight pitting edema with elevation of the serum Cl and 
decrease in 002 combining power- two cases. This disappeared 
without discontinuing therapy. 
6. Swelling and tenderness of the submaxillary gland - one 
case. Therapy was not discontinued. 
7. Urticarial rashes, usually associated with fever and a 
leukopenia appeared in five cases. In only two cases was the 
drug stopped, however. 
8. Mild jaundice. This was described in one case following 
twenty days of therapy; 0.8sm. thiouracil being taken daily. The 
reaction subsided completely within ten days after the drug was 
stopped and no interference with liver function could be detected. 
9. Hematuria - (microscopic) - one patient. 
From these results it appears that some form of toxic reaction 
has been observed in 16 or 11.8:1 of 135 patients who have re-
ceived thiouracil for the treatment of thyrotoxicosis. No fatal 
complications were found but two of the patients were severely ill. 
Eight of the reactions reported were very mild and seven were 
not considered sufficiently severe to justify the interruption 
of therapy. 
Astwood (55) in an ~palysis of sixty•two cases not included 
by .McGavack et al, reported about 10% showing major toxic effects. 
Each of these reactions came early in the course of therapy. He 
reported no evidence of chronic toxicity to date. The complication• 
seen included 
1._ Agranulocytosis - one case. This patient had a history 
of previous sensitivity to other drugs. 
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2. Marked leukopenia - one case. 
3. Febrile reactions - four cases, two of which were severe. 
Astwood suggests on th~ basis of his observations that the 
best indication of impend-ing danger of toxic reactions are the 
subjective sensations of the patient and the body temperature 
although routine white counts are also important. 
Of fifty-two pat:1.ents treated by Moore and his co-workers 
(53) and not included in McGavack's series, two cases of leukopenia, 
four oral infections possi_bly related to the drug and one case 
of generalized lymphadenopathy were reported. In two patients 
the development of a fever was associated with sensitivity to the 
drug. • 
Rose and McConnell (49) reporting on thirty-seven cases 
noted untoward reactions attributed to thiouracil in eight patients,. 
the most -important complication being severe leukopenia associated .. 
with pharyngitis and fever. which was observed in two cases. 
~--Therapy was eventually successfully resumed with small doses. 
In addition fourteen other patients, whose white blood counts 
were within normal limits prior to therapy, showed a fall to be-
low 5000 within 4 to 55 days after the drug was begun. In six 
of these patients the white count returned to normal.levels de-
spite continuation of therapy. Other toxic manifestations noted 
were: 
1. ~ild maculopapular facial eruptions - two patients. 
2. urticaria - two patients. 
3. myalgia and anorexia - one patient. 
4. prurit~s - one patient. 
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The authors advise that patients who develop urticaria or 
any other allergic manifestation be carefully observed when ther-
apy is resumed since other sensitivity phenomena may result. 
Of the various complications encountered with thiouracil 
the only one to cause appreciable concern is agranulocytosis. 
Not only has this been reported by a number of investigators 
(37) (38) (55) (61) (62) (63) but it has also been implicated 
in three deaths. 
Himsworth (64) has reported one fatal case of agranulocyto-
sis occurring during thiou~acil therapy but details as to total 
dosage and duration of treatment were not given. 
A second case was reported by Kahn and Stock (65). Their 
patient, a diabetic, received a total dosage of 30.8gm. in 54 days. 
In this case, the white blood count dropped to 1100 accompanied 
by the appearance of a rash and pharyngitis. Despite intensive 
J treatment, the patient died in a diebe~ic coma five days after 
the onset of the symptoms. In this case there seems to be little 
doubt that the diabet$s was contributory • 
• 
The third case, reported recently by ¥errer, Spain and 
Cathcart (66), was that of a seventy year old male who had re-
ceived 113.6gm. of the drug in 128 days, an excessive dosage by 
present standards. 
Rubinstein (63) following a case of thiouracil agranulocy-
tosis by serial bone marrow studies, was able to show that the 
cause of the agranulocytosis was arrest of maturation associated 
with hypoplasia of the myeloid elements of the bone marrow. On 
discontinuing the drug, complete hematological recovery followed, 
the bone marrow recovery prece4ing that of the peripheral blood. 
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Since the marrow has been de~onstrated to contain a relatively 
high.thiouracil concentration, and since the white cells contain 
a much higher concentration than the red cells (35) this predi-
lection of thiouracil for the white cells and the bone marrow 
may ~ell be the reason why the myeloid elements of the marrow 
are affected. Since agranulocytosis is only an infrequent compli- -
cation, it is not at all unlikely that a certain specific sensi-
tivity to the drug must probably also be present for this compli-
cation to occur. 
Summary 
There remains little doubt that thiouracil can el"fectively 
block the synthesis of thyroid hormone. Administered to hyper-
thyroid patients the value of such therapy is obvious. Advantages 
over other forms of therapy include the avoidance of surgical 
operation, the reproducible nature of the response, the lack of 
any evidence of the development of tolerance or refractiveness, 
and the ease with which the metabolic rate can be controlled at 
an~ desired level. 
The main disadvantage of thiouracil therapy is the occurrence 
of toxic reactions in a small percentage of cases. The use of 
small doses as now practiced may help to reduce the incidence or 
severity of such reactions. As thiouracil is only one of a number 
of active compounds it is quite likely that equally effective 
though less toxic substances_ will eventually be discovered. 
Dangerous toxic reactions are apparently quite rare; the 
more common reactions nay be such that tre~l.tment has to be dis-
continued but in such instances nothing has been lost. The sub-
sequent response to iodine remains unaffected and surgery can be 
• 
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performed when necessary without added danger. In many cases, it 
has been possible to continue therapy despite reactions, b~ de-
creasing the dosage, the blood picture and the patient being care-
fully followed. In others, cessation of the drug at the first 
signs of a reaction, followed by continuation of therapy a few 
days later has been successful. It is probably wise to give 
thiouracil with great care to any patient known to have afiy.al-
lergic symptoms. It is not unlikely that the more serious side -
effects resulting from the drug could probably be av6ided if the 
patients were instructed to seek medical advice as soon as abnormal 
symptoms are experienced. 
THIOURACIL AS AN AID IN THE PREOPERATIYE PREPARATION FOR 
THYROID.'OO'l'OVY 
The preparation of the thyrotoxic patient for thyroidectomy 
has undergone a gradual evolution in the attempt to bring the 
patient to surgery in.as nearly a normal state as possible. The 
ideal prepperative preparat~on would be a regimen of therapy 
which .would so modify the underlying metabolic abnormality as to 
bring the patient to the surgeon with no e•idence of thyrotoxicosis, 
allowing removal of the gland and permanent relief without sub-
jecting the patient to the hazards of surgery while thyrotoxic. 
Bed rest alone, with adequate sedation, accomplished a minimal 
but significant change in this direction. The introduct1 on of the 
use of iodine for this purpose by Plummer in 1923 (67) marked an 
important advance and was followed by a malked decrease in opera-
tive morbidity and mortality. The next period of thyroid surgery 
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was chiefly devoted to improvement in surgical technic. However, 
the fundamental problem sti~l remained of a patient undergoing 
operation suffering from a metabolic abnormality greatly ag-
gravated by the physiologic stress and local manipulation incident 
to thyroidectomy. 
The complications of thyroidectomy are divisible into three 
main groups: those related to surgery in general, such as hemorr-
hage and sepsis; those related to the peculiar anatomical rela-
tionships of the thyroid gland, such as nerve or parathyroid in-
jury; and lastly, those which stem from the pathologic physiol-
ogy of thyrotoxicosis, chiefly storm and postoperative thermal 
reactions. With competent surgery and asepsis, dangers from the 
first two of these groups can be minimized. The discovery of 
the anti-thyroid action of thiouracil and of its effect in re-
ducing the metabolic rate led at once to the hope that this drug 
would be useful in the preparation of the thyrotoxic patient for 
surgery and in the control of complications incident to this con-
dition (i.e. storm and post operative thermal react\. ons) 
· A survey of the literature has revealed some 121 cases where 
thiouracil has been used preparatory to thyroidectomy.(see table 
P· l.l 
above) From these data the following conclusions can be drawn: 
1. Thioura~il is superior to iodine as a preparation for 
thyroidectomy because, regardless of the degree of elevation of 
the metabolic rate prior to therapy, it will bring the pat~ent 
to operation with a normal metabolic rate. In a series by Moore 
et al (53) the preoperative metabolic response to thiouracil was 
found to differ strikingly from iodine in that iodine· treated 
cases showed a downward ahift in m~tabolic rate averaging about 
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twenty-.five points, whereas adequate thiouracil preparation re-
duced the rate to normal. With iodine, there was no resularity 
of response. 
2. The histologic change accompanying the decrease in 
metabolic rate is an intensification ot' the hyperplasia seen 
in thyrotoxicosis. Thiouracil produces an hyperplastic but non 
functioning goiter. 
B. Preliminary, or concomitant, iodine administration delays 
the thiouracil response. 
4. Toxic reactions occasionally occur. 
-5. The operative course in thyrotoxic patients treated pre-
operatively for five or six'weeks with thiouracil was remarkable 
only for its smoothness. Th~ reacted as would patients with a 
normal metabolism to a moderate surgical procedure, with no 
marked changes in pulse or blood pressure. The postoperative 
course was equally smooth and uneventful. {54) 
6. From the viewpoint of anesthesia, the induction and main-
tenance of these patients is like that of any patient with a 
normal metabolism. Only average amounts of preoperative sedation 
are necessary. Cycloprop&lle and oxygen.anesthesia has given 
excellent results. (54) 
7. Those thyrocardiac patients which have come to operation 
after preoperative preparation with thiouracil have done very 
well. The absence o.f severe postoperative reactions has helped 
materially in making their final recovery smooth and rapid· (53)(54) 
8. The It' eoperative use of thiouracil in severe hyperthy-
roidism shortens the time of treatment, reduces the hospital 
stay, and limits the procedure to a subtotal thyroidectomy. l56) 
The one disadvantage of thiouracil in the preparation of 
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patients for surgery lies in the fact that the hyperplasia re-
sulting with this drug is usually accompanied by an increased 
vascularity and friability which makes the gland more difficult 
to handle and renders hemostasis arduous. (53) (68) This dif-
ficulty has been solved, however, by the use of a short period 
of iodine therapy to involute the gland following reduction of 
th&metabolic rate with thiouracil. The Lahey Clinic has now 
operated successfully on several hundred cases following this 
routine. (57) (68) (69) 
Thiouracil Dpsage in Preoperative Preparation 
The preoperative preparation of ~hyrotoxic patients with 
thiouracil is considerably more simple than with iodine. Clute 
and Williams (54) have suggested the following routine. The 
patient is started on thiouracil in doses of 0.2gm. three times 
a day at about eight hour intervals. Within a day or two the 
patient is U$081ly sent home to take 0.4 or 0.6gm. thiouracil a 
day. The patients are permitted to carry on their usual work 
but requested to return at two week intervals for a check-up 
metabolism and blood tea~. Patients are treated for about five 
weeks preceding thyroidectomy and for about four to six days 
postoperatively. During the p~perative period, the patient 
is given thiamin chloride, 5mg. daily, and urged to eat food 
containing much carbohydrat~ and protein. 
Future Indications for Surgerl 
Until more adequate information on long term thiouracil 
therapy is available, the following future indications for thy-
roidectomy have been suggested. (54) These are based on the as-
sumption that hyperthyroidism can be fully controlled by the use 
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of this drug. 
1. Patients with a very large goiter. 
2. Patients who live in isolated areas and cannot 
readily have the frequent check up examinations required 
during thiouracil treatment. 
3. Patients who through ignorance or temperamental 
difficulties cannot be depended upon to·carefully f'ollow 
medical treatment. 
4. The small number of cases who have undesirable 
reactions to this drug. 
I 
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A SUMMARY OF THE POTENTIALITIES OF THIOURACIL IN MEDICINE 
1. Thiouracil vs operation in hyperthyroidism 
Whether thiouracil will prove to be a satisfactory 
substitute for the surgical treatment of diffuse toxic goiter 
cannot at present be stated due to limited experience with' 
this form of therapy. The chief adv!:lntages of' treatment with 
this agent would se~ to lie in the possibility of controlled 
suppression of thyroid hyperactivity and in the ready reversi-
bility of the effect of this drug. This would seem preferable 
to subtotal thyroidectomy with its inherent dangers of post-
operative myxedema and r~sidual or recurrent thyrotoxicosis, 
entirely apart from the ordinary surg~cal risk involved. 
2. Thiouracil promises to be of great value in cases in 
which operation is inadvisable or contraindicated. These 
include: 
a. Cases in which exophthalmos is prominent and there 
is danger of malignant exophthalmos following surgical re-
moval. (37) 
b. Cases with seve~hypertension. 
c. Cases who have psychotic tendencies. (55) 
d. Cases in thyrocardiacs. (54) 
3. Cases of persistent or recurrent toxjcity after thy-
roidectomy may be controlled with this drug. One such case 
with complete remission after cessation of therapy has now 
been followed for seven months. (45) Clute & Williams (54) 
have reported fifteen such cases, some having been subjected 
to two or three operations without results, all of whom have 
responded satisfactorJ,ly to thiouracil. 
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4. Thiouracil combined with X-ray therapy. 
The effectiveness of thiouracil in causing a remission 
of the acute symptoms of t·t)lyrotoxicos1s has suggested a combi-
nation of this therapy with irradi~ation of the gland as a 
substitute for the usual procedure of administration of iodine 
followed by thyroidectomy. Two cases so treated gave good re-
aults. ( 48) 
5. Thiouracil as·a therapeutic test 
This drug has proven valuable as a means of determining 
the presence of thyrotoxicosis in the so-ca,.lled cases of 
"apathetic" or "ma~ked" hyperthyroidism in which the evidence 
for the existence of a thyrotoxic state although suspected, is 
insufficient to warrant surgical interference. The difficulty 
of proving the existence of thyrotoxicosis in such patients 
is well known for they often present an atypical clinical pic-
ture of some other type of disease such as organic heart fai-
lure, gastro-intestinal disorders, psychoneurosis, (NCA especial-
ly) etc. Remission of symptoms or lack of response to thio-
uracil may aid the diagnosis. (48) 
6. Preoperative treatment with thiouracil is becoming a 
recognized therapeutic procedure. It is of especial value in: 
a. Cases where iodine therapy has had little or no 
effect on the basal metabolic rate. 
b. Cases who because of the sevetaity of their hyper-
thyroidism are unusually poor surgical risks, 
.c. Cases of similarly high surgical risk because of 
complicating conditions added to severe hyperthyroidism. 
So-called adenomas of the thyroid as a rule war-
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rant surgery whether they are toxic or not.· Formerly, their 
toxicity was feared as it did not respond satisfactorily to 
iodine. Thiouracil acts as readily in adenomas as it does in 
the diffusely hyperplastic gland although the former are not 
as quickly controlled. (55) Despite this fact, these tumefac-
tions still remain as a possible mechanical problem, and as the 
precursor of a cancerous lesion which develops in about 3.7% 
of all nodular goiters, Therefore, it seems wise to reserve 
thiouracil only for preoperative preparation in such eases 
rather than to undertake medical treatment alone. 
7. Thiouracil has advantages over iodine in the preoper-
ative management of thyrotoxic patients. 
a. It can be used in patients who either do not tolerate 
iodine or do not respond. 
b. Patients who are mishandled by too prolonged ad-
ministration of iodine can be adequately prepared for surgery 
with thiouracil. 
c. In the average case, neither intolerant nor ir-
responsive to iodine, an important advantage is seen in the 
fact that with the use of adequate thiouracil therapy the thy-
roid function can be decreased to the desired normal or even 
hypothyroid level. In contradistinction, the BMR in moderately 
severe or severe cases of thyrotoxicosis cannot as a rule be 
reduced to entirely normal levels with iodine and patients 
have to be operated upon in a more or less mild thyrotoxic 
condition. The operative and postoperative course is smoother 
and less dangerous if thyroid function has previously been de-
pressed to normal. (53) 
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8. The drug promises to be of special value in the 
thyrocardiacs. This group represents the patient carryins 
. . 
the worst surgical risk. These are usually patients in the 
older age-group, in whom the limited cardiac reserve of age 
has been completely absorbed by the excessive cardiac load 
of thyrotoxicosis and in whom therefore the added burden of 
operation is prone to initiate serious decompensation. In 
such cases much is to be gained by reducing the BMR to normal 
before operation. 
~ 9 •• The possibility of thyroid enlargement under thiouracil 
therapy has already.been mentioned. Whether individuals with 
very large goiters may experience a further growth of the gland 
with resulting pressure symptoms is still controversial. Suf• 
ficient data is not yet available to indic~te whether this is 
a real danger. 
10. At present the chief objection to the use of this drug 
is the possibility of tox3.c and allergic manifestations. There 
is good indication that the present use of decreased dosa8e 
combined with careful observation of the patient will limit 
the severity of these reactions to a minimum. 
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